{"id":"https://openalex.org/W7166406516","doi":null,"title":"Hypophysitis as a Manifestation of Neurotoxicity in the Treatment of Cancer","display_name":"Hypophysitis as a Manifestation of Neurotoxicity in the Treatment of Cancer","publication_year":2026,"publication_date":"2026-03-01","ids":{"openalex":"https://openalex.org/W7166406516"},"language":"ru","primary_location":{"id":"pmh:https://cyberleninka.ru/article/n/gipofizit-kak-proyavlenie-neyrotoksichnosti-pri-lechenii-onkologicheskih-zabolevaniy","doi":null,"is_oa":true,"landing_page_url":"https://cyberleninka.ru/article/n/gipofizit-kak-proyavlenie-neyrotoksichnosti-pri-lechenii-onkologicheskih-zabolevaniy","pdf_url":"https://cyberleninka.ru/article/n/gipofizit-kak-proyavlenie-neyrotoksichnosti-pri-lechenii-onkologicheskih-zabolevaniy/pdf","source":{"id":"https://openalex.org/S4210199184","display_name":"Innovative medicine of Kuban","issn_l":"2500-0268","issn":["2500-0268","2541-9897"],"is_oa":false,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"text"},"parent_works":[],"lineage":["https://openalex.org/W7166406516"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["doaj"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://cyberleninka.ru/article/n/gipofizit-kak-proyavlenie-neyrotoksichnosti-pri-lechenii-onkologicheskih-zabolevaniy/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114691919","display_name":"E. Yu. Krivitskaya","orcid":"https://orcid.org/0009-0002-4743-7907","observed_orcids":["https://orcid.org/0009-0002-4743-7907"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u041a\u0440\u0438\u0432\u0438\u0446\u043a\u0430\u044f \u0415\u043b\u0435\u043d\u0430 \u042e\u0440\u044c\u0435\u0432\u043d\u0430","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5074283340","display_name":"E. I. Zyablova","orcid":"https://orcid.org/0000-0002-6845-5613","observed_orcids":["https://orcid.org/0000-0002-6845-5613"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u0417\u044f\u0431\u043b\u043e\u0432\u0430 \u0415\u043b\u0435\u043d\u0430 \u0418\u0433\u043e\u0440\u0435\u0432\u043d\u0430","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10832","display_name":"Pituitary Gland Disorders and Treatments","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10832","display_name":"Pituitary Gland Disorders and Treatments","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.012000000104308128,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypophysitis","display_name":"hypophysitis","score":0.996999979019165},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.8399999737739563},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7390000224113464},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7319999933242798},{"id":"https://openalex.org/keywords/pituitary-enlargement","display_name":"pituitary enlargement","score":0.8169999718666077},{"id":"https://openalex.org/keywords/cancer-treatment-side-effects","display_name":"cancer treatment side effects","score":0.7720000147819519}],"concepts":[{"id":"https://openalex.org/C2780194577","wikidata":"https://www.wikidata.org/wiki/Q4120169","display_name":"Hypophysitis","level":4,"score":0.8938000202178955},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.821399986743927},{"id":"https://openalex.org/C2779491297","wikidata":"https://www.wikidata.org/wiki/Q3338704","display_name":"Neurotoxicity","level":3,"score":0.6814000010490417},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.663100004196167},{"id":"https://openalex.org/C81182388","wikidata":"https://www.wikidata.org/wiki/Q353963","display_name":"Complication","level":2,"score":0.6283000111579895},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5444999933242798},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.5388000011444092},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4837000072002411},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.3878999948501587},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.326200008392334},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.31859999895095825},{"id":"https://openalex.org/C2777658017","wikidata":"https://www.wikidata.org/wiki/Q156871","display_name":"Pituitary gland","level":3,"score":0.31130000948905945},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.29919999837875366},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2865000069141388},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2770000100135803},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.27379998564720154},{"id":"https://openalex.org/C2779075594","wikidata":"https://www.wikidata.org/wiki/Q8084905","display_name":"Autoimmune disease","level":3,"score":0.2712000012397766},{"id":"https://openalex.org/C2779281540","wikidata":"https://www.wikidata.org/wiki/Q5062122","display_name":"Central nervous system disease","level":2,"score":0.26840001344680786},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26350000500679016},{"id":"https://openalex.org/C3454156","wikidata":"https://www.wikidata.org/wiki/Q1144241","display_name":"Side effect (computer science)","level":2,"score":0.25929999351501465},{"id":"https://openalex.org/C2779618896","wikidata":"https://www.wikidata.org/wiki/Q107231","display_name":"Paralysis","level":2,"score":0.25929999351501465}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:https://cyberleninka.ru/article/n/gipofizit-kak-proyavlenie-neyrotoksichnosti-pri-lechenii-onkologicheskih-zabolevaniy","doi":null,"is_oa":true,"landing_page_url":"https://cyberleninka.ru/article/n/gipofizit-kak-proyavlenie-neyrotoksichnosti-pri-lechenii-onkologicheskih-zabolevaniy","pdf_url":"https://cyberleninka.ru/article/n/gipofizit-kak-proyavlenie-neyrotoksichnosti-pri-lechenii-onkologicheskih-zabolevaniy/pdf","source":{"id":"https://openalex.org/S4210199184","display_name":"Innovative medicine of Kuban","issn_l":"2500-0268","issn":["2500-0268","2541-9897"],"is_oa":false,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"text"},{"id":"pmh:oai:doaj.org/article:81699a9c4efe4ab0a6164c395b88c9eb","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/81699a9c4efe4ab0a6164c395b88c9eb","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u0418\u043d\u043d\u043e\u0432\u0430\u0446\u0438\u043e\u043d\u043d\u0430\u044f \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0430 \u041a\u0443\u0431\u0430\u043d\u0438, Vol 11, Iss 1-1, Pp 37-41 (2026)","raw_type":"article"}],"best_oa_location":{"id":"pmh:https://cyberleninka.ru/article/n/gipofizit-kak-proyavlenie-neyrotoksichnosti-pri-lechenii-onkologicheskih-zabolevaniy","doi":null,"is_oa":true,"landing_page_url":"https://cyberleninka.ru/article/n/gipofizit-kak-proyavlenie-neyrotoksichnosti-pri-lechenii-onkologicheskih-zabolevaniy","pdf_url":"https://cyberleninka.ru/article/n/gipofizit-kak-proyavlenie-neyrotoksichnosti-pri-lechenii-onkologicheskih-zabolevaniy/pdf","source":{"id":"https://openalex.org/S4210199184","display_name":"Innovative medicine of Kuban","issn_l":"2500-0268","issn":["2500-0268","2541-9897"],"is_oa":false,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7166406516.pdf","grobid_xml":"https://content.openalex.org/works/W7166406516.grobid-xml"},"referenced_works_count":8,"referenced_works":["https://openalex.org/W1185432402","https://openalex.org/W2036195858","https://openalex.org/W2113287405","https://openalex.org/W2911495259","https://openalex.org/W2954534439","https://openalex.org/W2954824018","https://openalex.org/W4225122608","https://openalex.org/W4388832417"],"related_works":["https://openalex.org/W3008421286","https://openalex.org/W7166421230","https://openalex.org/W2533633657","https://openalex.org/W4320922367","https://openalex.org/W3129366965","https://openalex.org/W3082372527","https://openalex.org/W4389436566","https://openalex.org/W2096060394","https://openalex.org/W2403550305","https://openalex.org/W1981428436"],"abstract_inverted_index":{"Neurological":[0],"toxicity":[1],"is":[2,20,35],"a":[3,21,31,53],"rare":[4],"but":[5],"highly":[6],"serious":[7],"\u2013":[8,14],"and":[9,70],"in":[10,56],"some":[11],"cases":[12],"fatal":[13],"complication":[15],"of":[16,23,26,41,48,59,65,72],"cancer":[17],"therapy.":[18,76],"Hypophysitis":[19],"manifestation":[22],"this":[24,60],"spectrum":[25],"adverse":[27],"effects,":[28],"being":[29],"not":[30],"classical":[32],"complication.":[33],"It":[34],"typically":[36],"associated":[37],"with":[38],"the":[39,49,57,63],"use":[40],"antiCTLA-4":[42],"agents.":[43],"Magnetic":[44],"resonance":[45],"imaging":[46],"(MRI)":[47],"sellar":[50],"region":[51],"plays":[52],"key":[54],"role":[55],"diagnosis":[58],"condition,":[61],"enabling":[62],"detection":[64],"pituitary":[66],"enlargement,":[67],"structural":[68],"alterations,":[69],"evaluation":[71],"disease":[73],"dynamics":[74],"during":[75]},"counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2026-06-28T00:00:00"}